90 related articles for article (PubMed ID: 7905326)
1. Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.
Simonsson B; Oberg G; Killander A; Björeman M; Börkholm M; Gahrton G; Hast R; Turesson I; Udén AM; Malm C
Stem Cells; 1993 Oct; 11 Suppl 3():73-6. PubMed ID: 7905326
[TBL] [Abstract][Full Text] [Related]
2. Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.
Simonsson B; Oberg G; Björeman M; Björkholm M; Carneskog J; Gahrton G; Hast R; Karl H; Lanng-Nielsen J; Löfvenberg E; Malm C; Turesson I; Udén AM; Vilén L; Weis-Bjerrum O
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S63-4. PubMed ID: 8769705
[TBL] [Abstract][Full Text] [Related]
3. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
4. Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up.
Simonsson B; Oberg G; Bjoreman M; Bjorkholm M; Carneskog J; Karlsson K; Gahrton G; Grimfors G; Hast R; Karle H; Linder O; Ljungman P; Nielsen JL; Nilsson J; Lofvenberg E; Malm C; Olsson K; Olsson-Stromberg U; Paul C; Stenke L; Stentoft J; Turesson I; Udén AM; Wahlin A; Vilén L; Weis-Bjerrum O
Acta Haematol; 2005; 113(3):155-62. PubMed ID: 15870485
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
6. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex.
Rowe JM; Rapoport AP; Ryan DH; Nilsson BI; Duerst RE; Packman CH; Abboud CN; DiPersio JF; Linder T; Wang N; Simonsson B; Liesveld JL
Bone Marrow Transplant; 1999 Nov; 24(10):1057-63. PubMed ID: 10578155
[TBL] [Abstract][Full Text] [Related]
8. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; LeMaistre CF; Spinolo J; Spitzer G; Yau J; Dicke K; Jagannath S; Deisseroth AB
Cancer; 1991 Jun; 67(12):2959-65. PubMed ID: 1675151
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia.
Nagamura-Inoue T; Tojo A; Ikebuchi K; Takahashi S; Ogura H; Shindoh E; Nagamura F; Uemura N; Watari K; Irie S; Setoyama M; Tajika K; Nakayama M; Nagayama H; Kobayashi Y; Shirafuji N; Sato N; Okamoto S; Ozawa K; Tani K; Asano S
Int J Hematol; 1997 Dec; 66(4):493-503. PubMed ID: 9479875
[TBL] [Abstract][Full Text] [Related]
10. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
Schulze E; Krahl R; Thalmeier K; Helbig W
Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
[TBL] [Abstract][Full Text] [Related]
11. Autologous transplantation for chronic myelogenous leukemia with mafosfamide-treated marrow.
Rizzoli V; Mangoni L; Almici C; Caramatti C; Dotti GP; Carlo-Stella C
Stem Cells; 1993 Oct; 11 Suppl 3():25-30. PubMed ID: 8298474
[TBL] [Abstract][Full Text] [Related]
12. Selective overshoot of Ph-negative blood hemopoietic cells after intensive idarubicin-containing regimen and their repopulating capacity after reinfusion.
Carella AM; Podestà M; Frassoni F; Pungolino E; Pollicardo N; Raffo MR; Ferrero R; Benvenuto F; Figari O; Giordano D
Stem Cells; 1993 Oct; 11 Suppl 3():67-72. PubMed ID: 7905325
[TBL] [Abstract][Full Text] [Related]
13. Karyotypic conversion by interferon as preparative treatment for autologous BMT in Ph positive CML. Italian Cooperative Study Group (ICSG) on Chronic Myeloid Leukemia.
Leuk Lymphoma; 1993; 11 Suppl 1():277-80. PubMed ID: 8251909
[TBL] [Abstract][Full Text] [Related]
14. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.
Carella AM; Podesta M; Frassoni F; Raffo MR; Pollicardo N; Pungolino E; Vimercati R; Sessarego M; Parodi C; Rabitti C
Bone Marrow Transplant; 1993 Sep; 12(3):267-71. PubMed ID: 7694724
[TBL] [Abstract][Full Text] [Related]
15. Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Swedish CML-group.
Simonsson B; Oberg G; Killander A; Björeman M; Björkholm M; Gahrton G; Stenke L; Turesson I; Udén AM; Malm C
Bone Marrow Transplant; 1994; 14 Suppl 3():S55-6. PubMed ID: 7535154
[No Abstract] [Full Text] [Related]
16. Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical results.
Alimena G; Meloni G; de Cuia MR; Rondinelli MB; Lo Coco F; Montefusco E; Mancini M; Pinto R; Nanni M; Cedrone M
Leuk Lymphoma; 1993; 11 Suppl 1():281-91. PubMed ID: 7902746
[TBL] [Abstract][Full Text] [Related]
17. Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.
Hernández-Boluda JC; Carreras E; Cervantes F; Marín P; Arellano-Rodrigo E; Rovira M; Solé F; Lloveras E; Espinet B; Ocejo A; Montserrat E
Haematologica; 2002 Jan; 87(1):17-22. PubMed ID: 11801461
[TBL] [Abstract][Full Text] [Related]
18. Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.
Simonsson B; Oberg G; Björeman M; Björkholm M; Gahrton G; Hast R; Killander A; Turesson I; Udén AM; Vikrot O
Leuk Lymphoma; 1992; 7 Suppl():55-7. PubMed ID: 1283548
[No Abstract] [Full Text] [Related]
19. Interferon-alpha in the treatment of chronic myeloid leukemia. A summary and an update of the Italian studies.
Rosti G; De Vivo A; Zuffa E; Baccarani M
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S11-3. PubMed ID: 8769692
[TBL] [Abstract][Full Text] [Related]
20. Use of interferon alfa-2a to treat hematologic relapse of chronic myelogenous leukemia after bone marrow transplantation.
Higano CS; Raskind WH; Singer JW
Acta Haematol; 1993; 89 Suppl 1():8-14. PubMed ID: 8475671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
